Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
Endometrial carcinoma is one of the important health issues addressed globally. Therefore, understanding the molecular pathogenesis of endometrial carcinoma for the purpose of prognostic and predictive markers remains in the centre of research. It has been reported in recently published literature t...
Saved in:
Main Authors: | Garima Chandrakar, Arvind Bhake |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2025-01-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/20482/75346_CE[Ra1]_F(SHU)_QC(SD_SS)_PF1(AG_OM)_PFA(SS)_PB(AG_IS)_PN(IS).pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The significance of the immunohistochemical method in diagnosing atypical endometrial polyps as manifestations of localized hyperplasia
by: O.V. Poslavska, et al.
Published: (2024-12-01) -
Investigation of Hyaluronan Synthase 2 and CD44 immune reactivity as a biomarker to predict Progesterone-Resistant Endometrial Hyperplasia without atypia: A retrospective case-control study
by: Emine Boybay, et al.
Published: (2024-12-01) -
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women
by: Zhen Li, et al.
Published: (2025-01-01) -
To do or not to do? – Endometrial biopsy in younger women with abnormal uterine bleeding
by: Sandra Lynn Jaya-Bodestyne, et al.
Published: (2025-03-01) -
Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2013-08-01)